AstraZeneca · 5 hours ago
Associate Director- Portfolio Contract Strategy, CVRM
AstraZeneca is a company focused on turning ideas into life-changing medicines. The Associate Director of Portfolio Contract Strategy will develop and implement contract strategies for key Market Access customers, ensuring alignment with business objectives and optimizing pricing strategies for their therapeutic areas.
BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Assist in the development of contract strategies and brings them through the approval/governance process
Directly partners with customer facing teams around prioritized key initiatives
Co-development and execution of negotiation strategies
Coordinate with team of analysts/specialists in operational activities such as rebates, chargebacks, government reporting, contract writing and process approvals
Monitors environment for shifts in trends or behaviors, interpret likely impact and suggest appropriate actions around life cycle contracting and pricing considerations
Develops deep understanding of competitive market conditions that affect pricing for individual brands, therapeutic areas and overall industry
Serves as a resource for Licensing and Business Development in assessing pricing on potential opportunities
Qualification
Required
Bachelor's degree; preferably in a relevant field (Marketing, Science, Economics or Finance)
3 years experience in the pharmaceutical or healthcare industry
Understanding of Market Access and Healthcare delivery systems
Analytical skills including problem solving, forecasting, contract development and financial modeling
Demonstrated negotiation & relationship building skills
Solution/Innovation mindset
Preferred
MBA/JD
Understanding of healthcare marketing and sales practices
Thorough understanding of pharmaceutical manufacturing business models with specific knowledge of brand team operation, brand planning and sales
Finance and/or analytics background
Contract development and negotiation experience
Clinical Acumen/Health Economics
Company
AstraZeneca
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.
Funding
Current Stage
Public CompanyTotal Funding
$5.26B2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B
Leadership Team
Recent News
2026-01-16
Genetic Engineering News
2026-01-16
Company data provided by crunchbase